The major responsibilities of this Core are to perform neuropathoiogic studies necessary to document and fully characterize the diagnostic features of Alzheimer disease (AD) and other neuropathoiogic changes associated with aging and cognitive impairment in brains of ADC subjects who come to autopsy, and to provide suitable tissues for research projects proposed by investigators. Therefore, in Specific Aim 1, we will maintain a bank of human brain tissue from subjects with AD or related dementias, and aged controls. The main functions will be: 1) to collect, prepare, evaluate, catalog, store, and distribute well-characterized postmortem brain tissue and other samples (including postmortem DNA) from deceased demented and control subjects for use in research;2) to report qualitative and quantitative diagnostic information to physicians, families, and researchers;3) to work with the Clinical Core to provide clinico pathologic correlation;and 4) to regularly update the central ADC and National Alzheimer Coordinating Center (NACC) databases with diagnostic and other related information on autopsied subjects. In order to enhance the neuropathoiogic characterization of brain tissue accessioned through this core, we will also focus on providing extensive quantitative neuropathoiogic evaluations for correlation with clinical and research data, including quantification of brain vascular alterations, cerebral white matter density, synapse loss, and neocortical neuritic dystrophy.
In Specific Aim 2, we will support investigator-initiated research on aging and neurodegenerative dementias by researchers at UT Southwestern by providing neuropathoiogic data and tissue samples for ongoing and future projects.
In Specific Aim 3, we will support multi-institutional studies of aging and neurodegenerative dementias, including LOAD and ADNI, again by providing neuropathoiogic data and tissue samples as necessary.
Hypertension, diabetes, obesity, metabolic syndrome and lipid abnormalities are major public health issues that influence the prevalence and course of dementia. An overarching goal of this ADC is to define more precisely the degree to which these issues are involved in aging and Alzheimer disease. Thorough neuropathoiogic characterization of brain tissue as proposed in this Core will provide the highest level of diagnostic certainty attainable and ensure that appropriate tissues are used for research projects.
|Neu, Scott C; Pa, Judy; Kukull, Walter et al. (2017) Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis. JAMA Neurol 74:1178-1189|
|Alosco, Michael L; Duskin, Jonathan; Besser, Lilah M et al. (2017) Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data Set. J Alzheimers Dis 57:953-968|
|Pandya, Seema Y; Lacritz, Laura H; Weiner, Myron F et al. (2017) Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition. Dement Geriatr Cogn Disord 43:204-214|
|Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738|
|Jutkowitz, Eric; MacLehose, Richard F; Gaugler, Joseph E et al. (2017) Risk Factors Associated With Cognitive, Functional, and Behavioral Trajectories of Newly Diagnosed Dementia Patients. J Gerontol A Biol Sci Med Sci 72:251-258|
|Jefferson-George, Kyra S; Wolk, David A; Lee, Edward B et al. (2017) Cognitive decline associated with pathological burden in primary age-related tauopathy. Alzheimers Dement 13:1048-1053|
|Evers, Bret M; Rodriguez-Navas, Carlos; Tesla, Rachel J et al. (2017) Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency. Cell Rep 20:2565-2574|
|Qian, Jing; Hyman, Bradley T; Betensky, Rebecca A (2017) Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design. JAMA Neurol 74:540-548|
|Moga, Daniela C; Taipale, Heidi; Tolppanen, Anna-Maija et al. (2017) A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. Drugs Aging 34:55-65|
|Devanand, Davangere P; Liu, Xinhua; Brown, Patrick J (2017) Impact of Functional Deficits in Instrumental Activities of Daily Living in Mild Cognitive Impairment: A Clinical Algorithm to Predict Progression to Dementia. Alzheimer Dis Assoc Disord 31:55-61|
Showing the most recent 10 out of 342 publications